EUCTR2012-001671-36-ES
Active, not recruiting
Not Applicable
A phase IV randomized, controlled clinical trial to compare the high flow oxygen therapy (group of intervention) opposite to the conventional oxygen therapy (group control) in patients with severe acute respiratory failure. - High flow and conventional oxigen therapy in patients with severe acute respiratory failure
Fundación para la Investigación Biomédica0 sitesJune 25, 2012
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Fundación para la Investigación Biomédica
- Status
- Active, not recruiting
- Last Updated
- 10 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •?Patients of both major sexes of 18 years joined UCI. ?severe acute respiratory failure defined clinical for: peripheral Saturation of oxygen (SatO2p by means of pulsioximetria) \<94 % respiratory superior Frequency to 30 r/min during 30 minutes with mask of venturi to 60 %, with or without pulmonary infiltrators in X\-ray photography of thorax.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range 95
- •F.1\.3 Elderly (\>\=65 years) yes
- •F.1\.3\.1 Number of subjects for this age range 95
Exclusion Criteria
- •?Glasgow \<11 ? Need of urgent intubation ?sharp Agitation without collaboration of the patient ? Shock with instability hemodinámica that does not answer to volume and aminas vasoactivas. ? Any patient who to criterion of the investigator could not expire with the specifications of the protocol
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 4
A phase IV, blinded, randomized controlled trial to compare the effectiveness of low pressure pneumoperitoneum during laparoscopic donor nephrectomy to optimize the quality-of-recovery during the early post-operative phasedonor nephrectomykidney donation1003843010038365NL-OMON40838niversitair Medisch Centrum Sint Radboud64
Completed
Phase 4
A Phase IV, monocentric, clinical trial to evaluate and compare the number of nicks and cuts among three different shaving systems on healthy Indian men.CTRI/2011/07/001890Procter and Gamble50
Active, not recruiting
Not Applicable
Clinical trial to evaluate the immune response and safety of a combined Tdap vaccine(Boostrix, GSK) and antipapilloma human virus vaccine (Gardasil) vaccine when administered with the meningococcal conjugate ACWY Novartis or placebo.Menveo is indicated for active immunization of adolescents (from 11 years of age) and adults at risk of exposure to Neisseria meningitidis groups A, C, W135 and Y, to prevent invasive disease.MedDRA version: 14.1Level: SOCClassification code 10021881Term: Infections and infestationsSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.1Level: LLTClassification code 10027276Term: Meningococcal meningitisSystem Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]EUCTR2011-000476-34-ITOVARTIS VACCINES AND DIAGNOSTICS S.R.L.800
Recruiting
Phase 4
Phase IV Efficacy Study of MMR Vaccine in Preventing or Reduction of Severity of COVID-19 in Healthcare Workers AdultsRBR-2xd6dkjniversidade Federal de Santa Catarina
Active, not recruiting
Phase 1
Clinical trial in children from 12 to 35 months of the flu vaccine to estimate efficacy against influenza and other respiratory infectionsEUCTR2019-001186-33-ESFISABIO400